TET2 and endometrium adenocarcinoma: After adjusting for possible confounders, stage, lymph node metastasis, and TET2 expression may be independent prognostic factors in patients with endometrial adenocarcinoma [hazard ratio (HR) = 13.553, 95% confidence interval (CI): 1.509–121.677, P = 0.020; HR = 15.359, 95% CI: 1.284–183.783, P = 0.031; HR = 14.520, 95% CI: 1.060–198.843, P = 0.045] (Table 2).